Evaluation of Lassa antiviral compound ST-193 in a guinea pig model. (49/107)

 (+info)

Pathogenesis of Lassa fever in cynomolgus macaques. (50/107)

 (+info)

Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case report. (51/107)

 (+info)

Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever. (52/107)

 (+info)

Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report. (53/107)

 (+info)

Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection. (54/107)

 (+info)

Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry. (55/107)

 (+info)

Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse model. (56/107)

 (+info)